Blog

Bluebird’s gene therapy shows promise in keeping lethal Lorenzo’s Oil disease in check – Endpoints News

Bluebird's gene therapy shows promise in keeping lethal Lorenzo's Oil disease in check
Endpoints News
After an average of 29 months following a one-time gene therapy infusion, a clear majority of boys suffering from lethal cases of cerebral adrenoleukodystrophy were alive and free of major complications from the disease — the primary endpoint in the

2017-10-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.